Multiple clinical studies and population-based cohorts demonstrate that COVID-19 infection triggers systemic inflammation and a hypercoagulable state that significantly increases the risk of acute myocardial infarction and other major cardiovascular events, particularly in the weeks following infection.
Evidence for · 3
Time-Critical Cardiovascular Risk After COVID-19: A Population-Based Analysis Across Variant Eras.
2026 · cited by 0
This population-based study demonstrates an elevated risk of major adverse cardiovascular events clustered within the first 30 days following SARS-CoV-2 infection.
See more details
More for · 2
Association of Acute-Phase IL-6 and SAA with Cardiovascular Events and Mortality Six Years After COVID-19 Infection: An Observational Cohort Study.
2026 · cited by 0
This observational study finds that acute inflammatory markers during COVID-19 infection are associated with long-term cardiovascular outcomes, including myocardial infarction.
Beyond recovery: long-term cardiovascular risks after severe COVID-19 requiring intensive care.
2026 · cited by 0
This matched cohort study shows that survivors of severe COVID-19 experience an increased risk of atherosclerotic cardiovascular disease (ASCVD) during follow-up.